Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CRNX | Common Stock | Options Exercise | $17.1K | +8.95K | +71.43% | $1.91* | 21.5K | Nov 1, 2021 | Direct | F1 |
transaction | CRNX | Common Stock | Sale | -$228K | -8.95K | -41.67% | $25.50 | 12.5K | Nov 1, 2021 | Direct | F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CRNX | Non-qualified stock option (Right to Buy) | Options Exercise | $0 | -8.95K | -42.54% | $0.00 | 12.1K | Nov 1, 2021 | Common stock | 8.95K | $1.91 | Direct | F1, F2 |
Id | Content |
---|---|
F1 | The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 30 days prior to the trading date. |
F2 | Stock option granted March 17, 2018 with one-third vesting on the first anniversary of the grant date and the remainder vesting in a series of twenty-four (24) successive equal monthly installments thereafter. |